Tamoxifen offered the same protection in mice with a form of retinitis pigmentosa.
Not exact matches
The results of the IBIS - II DCIS trial show that anastrozole is as effective as
tamoxifen for this type of breast cancer and could
offer a new treatment option for post-menopausal women.
But more importantly, because of their very different side - effects, anastrozole can be
offered as an alternative for patients who may not tolerate
tamoxifen as well or have previous illnesses making
tamoxifen unsuitable.
In addition to a range of antibodies, Abcam
offers over 4,000 pharmacological tools covering receptor agonists and antagonists, like
Tamoxifen Citrate and oestrogen receptor, which is also used in the control of gene expression.